Results 71 to 80 of about 7,415,932 (295)
Following a long stream of literature on the drivers of Mergers and Acquisition (M&A) activities, this study examines the effect of corporate leverage on several decisions of M&A deals in the context of the United Arab Emirates (UAE). Using M&A data from
Moataz Elmassri +2 more
doaj +1 more source
The characteristics of takeover targets: Evidence from food industry in Serbia [PDF]
This study analyses the characteristics of target companies from food industry that were taken over by foreign investors in the Serbian market. The aim of the study is to determine: Can future target companies be predicted based on the characteristics of
Andrašić Jelena +4 more
doaj
Leveraging language prior for infrared small target detection
IRSTD (InfraRed Small Target Detection) detects small targets in infrared blurry backgrounds and is essential for various applications. The detection task is challenging due to the small size of the targets and their sparse distribution in infrared small target datasets. Although existing IRSTD methods and datasets have led to significant advancements,
Pranav Singh Chib, Pravendra Singh
openaire +3 more sources
Structure‐forward targeting of claudins with synthetic binders
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source
Financial leverage decision by firm continues to attract interest from managers, analysts, researchers, scholars as well as policymakers because of its implications for the firm and its stakeholders. This paper investigates how the complexity of business,
Umar Farouk Abdulkarim +3 more
doaj +1 more source
Leveraging Large-Scale Biobanks for Therapeutic Target Discovery
Abstract Large biobanks, including the Million Veteran Program (MVP), the UK Biobank, and FinnGen, provide genetic association results for more than 1,000,000 individuals for hundreds of phenotypes. To select targets for pharmaceutical development, as well as to improve the understanding of existing targets, we ...
Ferolito, Brian R +43 more
openaire +2 more sources
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
Constant Leverage And Constant Cost Of Capital: A Common Knowledge Half-Truth
A typical approach for valuing finite cash flows is to assume that leverage is constant (usually as target leverage) and the cost of equity, Ke and the Weighted Average Cost of Capital, WACC are also assumed to be constant.
Ignacio Vélez–Pareja
doaj +1 more source
Emerging experimental and computational methods for studying redox‐regulated structural transitions
Redox reactions can reshape proteins and alter how they behave in cells, with important consequences for health and disease. This review explores emerging experimental and computational approaches for discovering these redox‐sensitive protein switches, revealing their structural effects, and predicting their behavior, opening new opportunities to ...
Tasneem Rass +2 more
wiley +1 more source
Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley +1 more source

